NIT
TCRT icon

NumerixS Investment Technologies’s Alaunos Therapeutics TCRT Stock Holding History

NumerixS Investment Technologies’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-72
Closed -$51K – 1261
2019
Q4 		$51K Buy
+72
New +$49.5K 0.01% 817
2018
Q1 		– Sell
-117
Closed -$73K – 1277
2017
Q4 		$73K Buy
+117
New +$84.1K 0.02% 782
2016
Q2 		– Sell
-124
Closed -$138K – 1238
2016
Q1 		$138K Buy
+124
New +$127K 0.02% 786
2015
Q2 		– Sell
-342
Closed -$553K – 743
2015
Q1 		$553K Buy
+342
New +$507K 0.1% 281

Other funds holding TCRT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NumerixS Investment Technologies's TCRT Position: Q1 2020 in Review

NumerixS Investment Technologies sold out of Alaunos Therapeutics (TCRT) in Q1 2020, closing a stake of 72 shares — an estimated $51K sold.

NumerixS Investment Technologies first reported a position in TCRT in Q1 2015 and held it in 4 quarters. The position peaked at $553K in Q1 2015. 146 funds tracked by Wall St. Rank hold TCRT as of Q1 2020.

  • NumerixS Investment Technologies reported no remaining Alaunos Therapeutics position as of Q1 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 72 Alaunos Therapeutics shares in Q1 2020, an estimated $51K.
  • NumerixS Investment Technologies first reported a position in Alaunos Therapeutics in Q1 2015 and held it in 4 quarters.
  • NumerixS Investment Technologies's Alaunos Therapeutics position peaked at $553K in Q1 2015.
  • 146 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2020.

Based on NumerixS Investment Technologies's 13F filing for Q1 2020, filed 15 May 2020.